Evidence-based articles for people using Ozempic and other GLP-1
Could GLP-1 Medications Actually Protect Your Brain. What the New Research Says When doctors started prescribing GLP-1 medications like semaglutide primarily for blood sugar control, nobody expected conversations about brain health to follow. A growing body of research is pointing toward som.
CagriSema: What 2026 Data Reveals About the Future of Obesity Treatment In 2024, when the first FLOW trial results were presented, the medical community needed a moment to absorb the magnitude of the impact. An average body weight reduction above 20%, with significant cardiovascular benefits.
FDA Approves Oral Semaglutide: What the New Indication Means for Weight Loss Treatment The FDA just made a move that changes the game for people looking to lose weight without needles. In March 2025, the agency approved Rybelsus (oral semaglutide) for a new indication: chronic weight manageme.
Tirzepatide vs Semaglutide: What the SURMOUNT-5 Trial Actually Tells Us If you have been following the world of weight loss medications, you have probably seen the headlines. Tirzepatide beats semaglutide. The numbers are striking, the buzz is real, and a lot of people are left wondering whi.
Retatrutide: What We Know About the New Drug That's Changing the Weight Loss Game The medical community has never seen anything quite like it. Retatrutide, developed by Eli Lilly, is the first triple-receptor peptide agonist targeting GLP-1, GIP, and glucagon approved for obesity treatment.
MASH and GLP-1: What 2026 Science Reveals About Reversing Liver Fibrosis For a long time, advanced liver fibrosis was thought to be a one-way street. That once the liver accumulated enough scar tissue, there was not much to do besides wait for the situation to worsen. That view is changing r.
Stopping GLP-1: what happens to your weight when you quit Anyone who has tried to lose weight with the help of medication knows that the hardest phase is not starting. When you finally reach a weight that seemed impossible, the urge is to enjoy the result and move on. But what if stopping th.
GLP-1 Biosimilars: What You Need to Know About Copies, Patents, and International Regulation When semaglutide started appearing everywhere, a question began circulating among patients and healthcare professionals: are the copies really equivalent to the original. The short answer is: it depen.
PCOS and GLP-1: what you need to know about insulin resistance and androgens When a woman receives a diagnosis of polycystic ovary syndrome, it is common to feel a mix of emotions. On one hand, finally having a name for symptoms that seemed not to make sense. On the other, dozens of question.
Severe Gastrointestinal Effects with GLP-1: What You Need to Know When someone starts using a GLP-1 medication like Wegovy or Mounjaro, it is practically certain they will face some kind of stomach discomfort at first. Mild nausea, feeling full sooner than expected, perhaps a bit of queasines.
Answer a few quick questions and get tailored guidance for your treatment.
or download the app
